1-6 of 6
Maria Eugenia Riveiro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The BET Inhibitor OTX015 (MK-8628) Shows in Vivo Antitumor Activity in Combination with Additional Targeted Agents in Diffuse Large B-Cell Lymphoma (DLBCL)

Eugenio Gaudio, Luciano Cascione, Maurilio Ponzoni, MD, Chiara Tarantelli, Elena Bernasconi, Maria Eugenia Riveiro, PhD, Esteban Cvitkovic, MD, Emanuele Zucca, Francesco Bertoni
Journal: Blood
Blood (2015) 126 (23): 5119.
https://doi.org/10.1182/blood.V126.23.5119.5119
Published: 2015
Journal Articles

Activity of OTX015 (MK-8628), a BET-Bromodomain Inhibitor, in Acute Myeloid Leukemia (AML) Progenitor Cells

Louise Roulin, Ashfaq Ali, Aline Masse, Marie-Magdelaine Coudé, Dominique Bluteau, Thorsten Braun, MD PhD, Jeannig Berrou, Olivier Bluteau, Marc Delord, Maria Eugenia Riveiro, Patrice EDOUARD Herait, MD, Jean Soulier, MD PhD, André Baruchel, MD, Claude Gardin, MD, Hervé Dombret, Raphaël Itzykson, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2588.
https://doi.org/10.1182/blood.V126.23.2588.2588
Published: 2015
Journal Articles

BET Bromodomain Inhibitor OTX015 Affects the Expression of Micrornas Involved in the Pathogenesis of Diffuse Large B-Cell Lymphoma

Luciano Cascione, Eugenio Gaudio, PhD, Elena Bernasconi, B.Sc., Chiara Tarantelli, Andrea Rinaldi, Monica Testoni, B.Sc., Riccardo Bomben, Valter Gattei, Ivo Kwee, PhD, Anastasios Stathis, MD, Maria Eugenia Riveiro, MD PhD, Emanuele Zucca, MD, Francesco Bertoni
Journal: Blood
Blood (2014) 124 (21): 4495.
https://doi.org/10.1182/blood.V124.21.4495.4495
Published: 2014
Journal Articles

The BET-Bromodomain Inhibitor OTX015 Is Active As a Single Agent and in Combination with Other Targeted Drugs in Preclinical Models of Mantle Cell Lymphoma

Elena Bernasconi, B.Sc., Chiara Tarantelli, Eugenio Gaudio, PhD, Ivo Kwee, Andrea Rinaldi, Luciano Cascione, Anastasios Stathis, MD, Maria Eugenia Riveiro, MD PhD, Emanuele Zucca, MD, Francesco Bertoni
Journal: Blood
Blood (2014) 124 (21): 3113.
https://doi.org/10.1182/blood.V124.21.3113.3113
Published: 2014
Journal Articles

Bromodomain Inhibition By OTX015 Regulates c-MYC and HEXIM1 in a Panel of Human Acute Leukemia Cell Lines

Marie-Magdelaine Coudé, Thorsten Braun, Jeannig Berrou, Mélanie Dupont, Raphael Itzykson, Aline Masse, Emmanuel Raffoux, MD, Maria Eugenia Riveiro, Patrice Herait, MD, Andre Baruchel, MD, Hervé Dombret, MD PhD, Claude Gardin
Journal: Blood
Blood (2014) 124 (21): 5957.
https://doi.org/10.1182/blood.V124.21.5957.5957
Published: 2014
Journal Articles

Preclinical Evaluation of the BET-Bromodomain (BET-BRD) Inhibitor OTX015 in Leukemia Cell Lines Harboring the JAK2 V617F Mutation

Maria Eugenia Riveiro, PhD, Lucile Astorgues-Xerri, PhD, Charlotte Canet-jourdan, Mohamed Bekradda, MD, Esteban Cvitkovic, MD, Patrice Herait, MD, Eric Raymond, MD PhD
Journal: Blood
Blood (2014) 124 (21): 873.
https://doi.org/10.1182/blood.V124.21.873.873
Published: 2014